Elana Bernstein, MD, MSc

Columbia University
New York, NY, United States

Dr. Bernstein is a clinical investigator who studies lung disease in systemic sclerosis, post-lung transplant outcomes of adults with systemic autoimmune rheumatic diseases, and the relationship between autoimmunity and interstitial lung disease. She is an Assistant Professor of Medicine in the Division of Rheumatology at Columbia University College of Physicians and Surgeons, and Director of the Columbia/NYP Scleroderma Program.

Boehringer Ingelheim (Individual(s) Involved: Self; Ongoing): Advisory board participant, Consultant, Grant/Research Support, Other Financial or Material Support; Corbus Pharmaceuticals (Individual(s) Involved: Self; Terminated): Grant/Research Support; Eicos (Individual(s) Involved: Self; Terminated): Grant/Research Support; Kadmon (Individual(s) Involved: Self; Ongoing): Grant/Research Support; Pfizer (Individual(s) Involved: Self; Ongoing): Grant/Research Support

Presentation(s):

• 12S146: Extrapulmonary Manifestations of Systemic Sclerosis: The Heart and Esophagus

  Saturday, November 12, 2022
  5:00 PM – 6:00 PM Eastern Time

• 13S106: Abstracts: Measures and Measurement of Healthcare Quality (0570–0573)

  Sunday, November 13, 2022
  8:00 AM – 9:00 AM Eastern Time

• 1659: FAM13A (Family with Sequence Similarity 13 Member A) Polymorphism Is Associated with Presence of a Radiographic Usual Interstitial Pneumonia Pattern in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

  Monday, November 14, 2022
  9:30 AM – 9:40 AM Eastern Time

• Scleroderma and ILD

  Monday, November 14, 2022
  11:00 AM – 11:20 AM Eastern Time